The introduction of DPPIV/CD26 in ovarian cancer cells produces a significant reduction in both, the migration and invasive potential by controlling the E-cadherin expression, a protein involved in cell adhesion [41]. This evidence concerns the gene FAP and ovarian carcinoma.